Helle Kristensen

Title: Helle Kristensen: Innovator in Pharmaceutical Formulations

Introduction

Helle Kristensen is a notable inventor based in Slangerup, Denmark. She has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations for treating overactive bladder conditions. With a total of 4 patents to her name, her work has had a meaningful impact on patient care.

Latest Patents

One of her latest patents is focused on "Transdermally administered tolterodine as an anti-muscarinic agent for the treatment of overactive bladder." This invention includes a set of formulations containing tolterodine and its derivatives, designed for various modes of administration, including transdermal and oral routes. The goal is to effectively manage symptoms associated with overactive bladder. Another significant patent is for a "Therapeutic formulation for administering tolterodine with controlled release." This method aims to maintain a consistent serum level of the active ingredient for at least 24 hours, providing a stable treatment option for patients with unstable or overactive urinary bladders.

Career Highlights

Helle Kristensen has worked with prominent companies in the pharmaceutical industry, including Pharmacia AB and Pharmacia & Upjohn AB. Her experience in these organizations has allowed her to refine her expertise in drug formulation and development.

Collaborations

Throughout her career, Helle has collaborated with talented professionals, including Ulla Hoeck and Lene Orup Jacobsen. These partnerships have contributed to her innovative work and the successful development of her patents.

Conclusion

Helle Kristensen's contributions to pharmaceutical innovations, particularly in the treatment of overactive bladder, highlight her role as a significant inventor in the field. Her patents reflect her commitment to improving patient outcomes through effective drug formulations.